ResMed (NYSE:RMD) is a company whose shares are active, trading 1.2% higher to $44.48. The Dow is down 0.3% to 13,499 and the S&P is currently trading fractionally lower to 1,471.
In the past 52 weeks, ResMed share prices have been bracketed by a low of $25.69 and a high of $44.65 and are now at $44.48, 73% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 0.5%.
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
ResMed (NYSE:RMD) defies analysts with a current price ($44.48) 4.9% above its average consensus price target of $42.32. The stock should discover initial support at its 50-day moving average (MA) of $41.47 and subsequent support at its 200-day MA of $36.38.